Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Bayer Aktiengesellschaft
- Roche
Comparative performance (base 100)
Each asset is worth 100 at October 13, 2025; a value of 120 means +20% since that date (latest common date: October 12, 2026).
Bonds and private debt have no comparable price series: they appear only in the table.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Bayer AktiengesellschaftStock | RocheStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | +52.6% | Indisponible |
| Annualized performanceAverage annual return that would produce the same total performance. | +52.8% | Indisponible |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 42.2% | Indisponible |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −31.4% | Indisponible |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 1.46 | Indisponible |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.5% | Indisponible |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 48.1B $ | Indisponible |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | Indisponible | Indisponible |
| Price-to-SalesMarket capitalization divided by annual revenue. | 1.1 | Indisponible |
| Net marginShare of revenue retained as profit. | −3.8% | Indisponible |
| Return on equityReturn on equity (ROE). | −5.7% | Indisponible |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +1.2% | Indisponible |
| Dividend yieldAnnual dividend relative to the share price. | 0.27% | Indisponible |
| Debt / equityFinancial debt relative to shareholders' equity. | 129% | Indisponible |
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.